203 related articles for article (PubMed ID: 37933308)
1. Primary Hepatic Neuroendocrine Carcinoma with Metastasis to the Mesentery: A Case Report.
Fernández-Ferreira R; Romero-López U; Robles-Aviña JA; Rivas-Mendoza UN; González-Camacho C; Valero-Gómez A; Barquet-Mata OA; Reyes-Gabiño A; Tovar-Figueroa KA; Ramírez-Villagrán V
Case Rep Oncol; 2023; 16(1):681-697. PubMed ID: 37933308
[TBL] [Abstract][Full Text] [Related]
2. Clinical features and outcomes of primary hepatic neuroendocrine carcinomas.
Park CH; Chung JW; Jang SJ; Chung MJ; Bang S; Park SW; Song SY; Chung JB; Park JY
J Gastroenterol Hepatol; 2012 Aug; 27(8):1306-11. PubMed ID: 22414232
[TBL] [Abstract][Full Text] [Related]
3. Primary hepatic neuroendocrine carcinoma: report of two cases and literature review.
Zhao ZM; Wang J; Ugwuowo UC; Wang L; Townsend JP
BMC Clin Pathol; 2018; 18():3. PubMed ID: 29507528
[TBL] [Abstract][Full Text] [Related]
4. Primary hepatic neuroendocrine carcinoma diagnosed by needle biopsy: a case report.
Seki Y; Sakata H; Uekusa T; Momose H; Yoneyama S; Hidemura A; Tajima Y; Suzuki H; Ishimaru M
Surg Case Rep; 2021 Nov; 7(1):236. PubMed ID: 34727269
[TBL] [Abstract][Full Text] [Related]
5. Comparative Clinical Analysis of Gastroenteropancreatic Neuroendocrine Carcinomas with Liver Metastasis and Primary Hepatic Neuroendocrine Carcinomas.
Qiu MJ; Chen YB; Bi NR; Yang SL; He XX; Xiong ZF
Dis Markers; 2018; 2018():9191639. PubMed ID: 30416612
[TBL] [Abstract][Full Text] [Related]
6. Combination therapies for primary hepatic neuroendocrine carcinoma: a case report.
Nakatake R; Ishizaki M; Matui K; Yanagimoto H; Inoue K; Kaibori M; Kawaguchi Y; Kon M
Surg Case Rep; 2017 Sep; 3(1):102. PubMed ID: 28895097
[TBL] [Abstract][Full Text] [Related]
7. Primary hepatic neuroendocrine tumor with multiple liver metastases: A case report with review of the literature.
Yang K; Cheng YS; Yang JJ; Jiang X; Guo JX
World J Gastroenterol; 2015 Mar; 21(10):3132-8. PubMed ID: 25780316
[TBL] [Abstract][Full Text] [Related]
8. Neuroendocrine Carcinoma of Gall Bladder: A Series of 19 Cases with Review of Literature.
Kamboj M; Gandhi JS; Gupta G; Sharma A; Pasricha S; Mehta A; Chandragouda D; Sinha R
J Gastrointest Cancer; 2015 Dec; 46(4):356-64. PubMed ID: 26208508
[TBL] [Abstract][Full Text] [Related]
9. Combined primary hepatic neuroendocrine carcinoma and hepatocellular carcinoma with aggressive biological behavior (adverse clinical course): A case report.
Okumura Y; Kohashi K; Wang H; Kato M; Maehara Y; Ogawa Y; Oda Y
Pathol Res Pract; 2017 Oct; 213(10):1322-1326. PubMed ID: 28647212
[TBL] [Abstract][Full Text] [Related]
10. Primary hepatic neuroendocrine tumor with multiple liver metastases: A case report with literature review.
Xia Y; Zhang L; Wu H; Qiao L; Xia L
J Int Med Res; 2020 Jun; 48(6):300060520932114. PubMed ID: 32589085
[TBL] [Abstract][Full Text] [Related]
11. Primary hepatic neuroendocrine tumour with multiple liver metastases: A case report with literature review.
Yu WM; Li R; Sun BL; Du JK; Tuo HF
Int J Surg Case Rep; 2021 Dec; 89():106590. PubMed ID: 34784532
[TBL] [Abstract][Full Text] [Related]
12. A case of neuroendocrine carcinoma with massive invasion to the liver and multiorgan causing acute liver failure.
Ogasawara Y; Ito N; Kogiso T; Yoshizawa S; Nagashima Y; Tokushige K
Clin J Gastroenterol; 2023 Aug; 16(4):580-587. PubMed ID: 37191837
[TBL] [Abstract][Full Text] [Related]
13. Primary hepatic neuroendocrine carcinoma: clinical analysis of 11 cases.
Huang YQ; Xu F; Yang JM; Huang B
Hepatobiliary Pancreat Dis Int; 2010 Feb; 9(1):44-8. PubMed ID: 20133228
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Metastatic Patterns Among Neuroendocrine Tumors, Neuroendocrine Carcinomas, and Nonneuroendocrine Carcinomas of Various Primary Organs.
Park HK; Kwon GY
J Korean Med Sci; 2023 Mar; 38(11):e85. PubMed ID: 36942393
[TBL] [Abstract][Full Text] [Related]
15. Neuroendocrine Carcinomas of the Uterine Cervix, Endometrium, and Ovary Show Higher Tendencies for Bone, Brain, and Liver Organotrophic Metastases.
Park HK
Curr Oncol; 2022 Oct; 29(10):7461-7469. PubMed ID: 36290864
[TBL] [Abstract][Full Text] [Related]
16. The efficacy of oxaliplatin, surufatinib, and camrelizumab on neuroendocrine carcinoma: a case report and literature review.
Wang X; Hu S; Su F; Lin J; Duan J; Tan H; Tan H
Ann Transl Med; 2022 Nov; 10(22):1254. PubMed ID: 36544653
[TBL] [Abstract][Full Text] [Related]
17. [Diagnosis and treatment of primary hepatic neuroendocrine carcinoma].
Xu K; Chen Y; Chen M; Zhang W; Wang Y; Ji W; Wang H; Xin X; Feng J; Li Y; Yan L
Zhonghua Zhong Liu Za Zhi; 2015 Jun; 37(6):451-5. PubMed ID: 26463150
[TBL] [Abstract][Full Text] [Related]
18. A Practical Approach to the Classification of WHO Grade 3 (G3) Well-differentiated Neuroendocrine Tumor (WD-NET) and Poorly Differentiated Neuroendocrine Carcinoma (PD-NEC) of the Pancreas.
Tang LH; Basturk O; Sue JJ; Klimstra DS
Am J Surg Pathol; 2016 Sep; 40(9):1192-202. PubMed ID: 27259015
[TBL] [Abstract][Full Text] [Related]
19. Primary hepatic neuroendocrine carcinoma with a cholangiocellular carcinoma component in one nodule.
Kano Y; Kakinuma S; Goto F; Azuma S; Nishimura-Sakurai Y; Itsui Y; Nakagawa M; Kudo A; Tanabe M; Kirimura S; Amano T; Ito T; Akashi T; Asahina Y; Watanabe M
Clin J Gastroenterol; 2014 Oct; 7(5):449-54. PubMed ID: 26184027
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of Chemotherapy versus Transcatheter Arterial Chemoembolization in Patients with Advanced Primary Hepatic Neuroendocrine Carcinoma and an Analysis of the Prognostic Factors: A Retrospective Study.
Li S; Niu M; Deng W; Li N; Wei C; Zhang C; Luo S
Cancer Manag Res; 2021; 13():9085-9093. PubMed ID: 34916851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
